deepull — Series A · €3.5M

DeepUll is based at the Barcelona Science Park and is developing a rapid diagnostic system for early-stage sepsis. It closed a €3.5M Series A co-led by Alta Life Sciences and Kurma Partners, with Axis and Sofimac Innovation (Pertinence Invest 2) also investing, to validate the technology and build its first prototypes.

LeadAlta Life Sciences, Kurma Partners RoundSeries A Announced7 Jul 2020 CityBarcelona SectorHealthtech & Bio · Healthtech / Diagnostics Source B

Something wrong? Suggest a correction →